PAPER Matura S, Prvulovic D, Butz M, Hartmann D, Sepanski B, Linnemann K, Oertel-Knöchel V, Karakaya T, Fußer F, Pantel J, van de Ven V
SEARCH RESULTS
332389 RESULTS
PAPER Frampton JE
Rivastigmine transdermal patch 13.3 mg/24 h: a review of its use in the management of mild to moderate Alzheimer's dementia.
Drugs Aging. 2014 Aug;31(8):639-49. PubMed.PAPER Cacabelos R, Torrellas C
Epigenetic drug discovery for Alzheimer's disease.
Expert Opin Drug Discov. 2014 Sep;9(9):1059-86. Epub 2014 Jul 3 PubMed.PAPER Park SJ, Ahn YJ, Oh SR, Lee Y, Kwon G, Woo H, Lee HE, Jang DS, Jung JW, Ryu JH
Amyrin attenuates scopolamine-induced cognitive impairment in mice.
Biol Pharm Bull. 2014;37(7):1207-13. PubMed.PAPER White MR, Kandel R, Tripathi S, Condon D, Qi L, Taubenberger J, Hartshorn KL
Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes.
PLoS One. 2014;9(7):e101364. Epub 2014 Jul 2 PubMed.PAPER Okumura H, Itoh SG
Amyloid fibril disruption by ultrasonic cavitation: nonequilibrium molecular dynamics simulations.
J Am Chem Soc. 2014 Jul 30;136(30):10549-52. Epub 2014 Jul 9 PubMed.PAPER Martinez-Ramirez S, Greenberg SM, Viswanathan A
Cerebral microbleeds: overview and implications in cognitive impairment.
Alzheimers Res Ther. 2014;6(3):33. Epub 2014 Jun 11 PubMed.PAPER Jochemsen HM, Teunissen CE, Ashby EL, van der Flier WM, Jones RE, Geerlings MI, Scheltens P, Kehoe PG, Muller M
The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease.
Alzheimers Res Ther. 2014;6(3):27. Epub 2014 May 15 PubMed.PAPER Wang S, Yu Y, Geng S, Wang D, Zhang L, Xie X, Wu B, Li C, Xu H, Li X, Hu Y, Zhang L, Kaether C, Wang B
A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer's disease model.
Alzheimers Res Ther. 2014;6(3):26. Epub 2014 May 12 PubMed.PAPER Sasaki S, Horie Y
The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.
Dement Geriatr Cogn Dis Extra. 2014 May;4(2):131-9. Epub 2014 May 21 PubMed.PAPER Tariot PN, Wirth Y, Graham SM, Tocco M, Fokkens J
Important error in 'systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias' by muayqil and camicioli.
Dement Geriatr Cogn Dis Extra. 2014 May;4(2):122-4. Epub 2014 May 20 PubMed.PAPER Martinelli JE, Cecato JF, Bartholomeu D, Montiel JM
Comparison of the diagnostic accuracy of neuropsychological tests in differentiating Alzheimer's disease from mild cognitive impairment: can the montreal cognitive assessment be better than the cambridge cognitive examination?
Dement Geriatr Cogn Dis Extra. 2014 May;4(2):113-21. Epub 2014 May 20 PubMed.PAPER Zhang Y, Ma RH, Li XC, Zhang JY, Shi HR, Wei W, Luo DJ, Wang Q, Wang JZ, Liu GP
Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice.
Front Aging Neurosci. 2014;6:123. Epub 2014 Jun 17 PubMed.PAPER Bhattacharjee S, Zhao Y, Lukiw WJ
Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update.
Front Aging Neurosci. 2014;6:116. Epub 2014 Jun 17 PubMed.PAPER Abuhassan K, Coyle D, Maguire L
Compensating for thalamocortical synaptic loss in Alzheimer's disease.
Front Comput Neurosci. 2014;8:65. Epub 2014 Jun 17 PubMed.Current Filters
No filters selected